MedTrace Logo

Berberine and Cinnamon in Management of Diabetes

NCT05570357 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2024-06-11

No results posted yet for this study

Summary

In this randomized clinical trial, patients with diabetes will be randomly assigned to receive either Berberine, and Cinnamon supplements or placebo for 12 weeks. Then the glycemic characteristics will be compared in two groups.

Conditions

Interventions

DIETARY_SUPPLEMENT

Berberine+Cinnamon (TDS)

The supplements contains 400 mg Berberine, and 200 mg Cinnamon extract

OTHER

Placebo (TDS)

Placebo contains Maltodexterin

Sponsors & Collaborators

  • National Nutrition and Food Technology Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2023-01-01
Completion
2023-02-10

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05570357 on ClinicalTrials.gov